In vitro characterization of the glucuronidation pathways of licochalcone A mediated by human UDP-glucuronosyltransferases

References

• Bernard O, Guillemette C. (2004). The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos 32:775–8.
   PubMed Web of Science ®Google Scholar
• Caldwell J, Gardner I, Swales N. (1995). An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion. Toxicol Pathol 23:102–14.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. (2005). Pharmacopoeia of the People's Republic of China. Beijing: Chemical Industry Press.
   Google Scholar
• Fried MW, Navarro VJ, Afdhal N, et al. (2012). Silymarin in NASH and C hepatitis (SyNCH) Study Group. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA 308:274–82.
   PubMed Web of Science ®Google Scholar
• Friis-Møller A, Chen M, Fuursted K, et al. (2002). In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med 68:416–9.
   PubMed Web of Science ®Google Scholar
• Guo B, Fang ZZ, Yang L, et al. (2015). Tissue and species differences in the glucuronidation of glabridin with UDP-glucuronosyltransferases. Chem Biol Interact 231:90–7.
   PubMed Web of Science ®Google Scholar
• Haraguchi H, Ishikawa H, Mizutani K, et al. (1998). Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 6:339–47.
   PubMed Web of Science ®Google Scholar
• Hecht JR. (1998). Gastrointestinal toxicity or irinotecan. Oncology (Williston Park, NY) 12:72–8.
   PubMed Web of Science ®Google Scholar
• He W, Wu JJ, Ning J, et al. (2015). Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice. Toxicol In Vitro 29:1569–76.
   PubMed Web of Science ®Google Scholar
• Higashi E, Ando A, Iwano S, et al. (2014). Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig. Biopharm Drug Dispos 35:313–20.
   PubMed Web of Science ®Google Scholar
• Hu G, Siu SO, Li S, et al. (2012). Metabolism of calycosin, an isoflavone from Astragali Radix, in zebrafish larvae. Xenobiotica 42:294–303.
   PubMed Web of Science ®Google Scholar
• Kolbe L, Immeyer J, Batzer J, et al. (2006). Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 298:23–30.
   PubMed Web of Science ®Google Scholar
• Liang SC, Ge GB, Liu HY, et al. (2011). Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC–ESI-MS. J Pharm Biomed Anal 54:236–41.
   PubMed Web of Science ®Google Scholar
• Liu JM, Wang QL, Yao TW, et al. (2014). Research on distribution and dosage of liquorice. Chin Arch Tradit Chin Med 32:3024–3024.
   Google Scholar
• Meza-Junco J, Chu QS, Christensen O, et al. (2009). UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib. Cancer Chemother Pharmacol 65:1–4.
   PubMed Web of Science ®Google Scholar
• Miners JO, Bowalgaha K, Elliot DJ, et al. (2011). Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation. Drug Metab Dispos 39:644–52.
   PubMed Web of Science ®Google Scholar
• Nadelmann L, Tjørnelund J, Hansen SH, et al. (1997a). Synthesis, isolation and identification of glucuronides and mercapturic acids of a novel antiparasitic agent, licochalcone A. Xenobiotica 27:667–80.
   PubMed Web of Science ®Google Scholar
• Nadelmann L, Tjørnelund J, Christensen E, et al. (1997b). High-performance liquid chromatographic determination of licochalcone A and its metabolites in biological fluids. J Chromatogr B Biomed Sci Appl 695:389–400.
   PubMed Web of Science ®Google Scholar
• Nagar S, Blanchard RL. (2006). Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev 38:393–400.
   PubMed Web of Science ®Google Scholar
• Park MR, Kim SG, Cho IA, et al. (2015). Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells. Food Chem Toxicol 77:34–43.
   PubMed Web of Science ®Google Scholar
• Shibata S. (2000). A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120:849–62.
   PubMed Web of Science ®Google Scholar
• Shiratani H, Katoh M, Nakajima M, et al. (2008). Species differences in UDP-glucuronosyltransferase activities in mice and rats. Drug Metab Dispos 36:1745–52.
   PubMed Web of Science ®Google Scholar
• Wen ZM, Martin DE, Bullock P, et al. (2006). Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP glucuronosyltransferases and species differences. Drug Metab Dispos 35:440–8.
   PubMed Web of Science ®Google Scholar
• Xiao XY, Hao M, Yang XY, et al. (2011). Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett 302:69–75.
   PubMed Web of Science ®Google Scholar
• Xin H, Qi XY, Wu JJ, et al. (2016). Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases. Food Chem Toxicol 90:112–22.
   PubMed Web of Science ®Google Scholar
• Yo YT, Shieh GS, Hsu KF, et al. (2009). Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway. J Agric Food Chem 57:8266–73.
   PubMed Web of Science ®Google Scholar
• Zhang QY, Ye M. (2009). Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). J Chromatogr A 1216:1954–69.
   PubMed Web of Science ®Google Scholar
• Zhang DL, Zhang DX, Cui D, et al. (2007). Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism. Drug Metab Dispos 35:2270–80.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bai M, Zhang B, et al. (2015). Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation. Sci Rep 5:9463.
   PubMed Web of Science ®Google Scholar
• Zhu LL, Ge GB, Liu Y, et al. (2012). Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9. Xenobiotica 42:1001–8.
   PubMed Web of Science ®Google Scholar
• Ziegler HL, Hansen HS, Staerk D, et al. (2004). The antiparasitic compound licochalcone a is a potent echinocytogenic agent that modifies the erythrocyte membrane in the concentration range where antiplasmodial activity is observed. Antimicrob Agents Chemother 48:4067–71.
   PubMed Web of Science ®Google Scholar
• Zucker SD, Qin X, Rouster SD, et al. (2001). Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci USA 98:12671–6.
   PubMed Web of Science ®Google Scholar